Ophthalmology and Optometry Coding Alert

Reader Questions:

Is Routine Reporting of 92002, V72.0 OK?

Question: Our office has been coding exams (routine exams) as 92002 and V72.0 when we don't see anything wrong. Would this raise any red flags?

Texas Subscriber

Answer: No. You may use the general ophthalmological services code 92002 (Ophthalmological services: medical examination and evaluation with initiation of diagnostic and treatment program; intermediate, new patient) with V72.0 (Special investigations and examinations; examination of eyes and vision). The V code indicates that the patient presented for a routine vision exam or a preventive service. Listing no additional diagnosis tells the insurer that you did not find or treat the patient for any condition or problem.

Coverage: If a patient has a medical-only insurance policy, the plan may not cover a claim for 92002 with V72.0 as this diagnosis may be considered routine vision screening. But Blue Cross Blue Shield of Texas will pay this combination for beneficiaries who have a routine vision rider on their health insurance policies.

You might, however, raise a red flag -- or trigger a denial -- if you code a routine eye exam, in which you found no problem, with an E/M code, such as 99212 (Office or other outpatient visit for the evaluation and management of an established patient ...). The office visit codes are typically used to report problem-related visits. Many insurers have system edits in place that will reject a screening diagnosis code (such as V72.0) with what they consider a problem-related code (for instance, 99201-99215).

Experts say: Most insurers have a preferred way of billing their routine exams. For example, Blue Cross Blue Shield of Texas will pay routine exams with a V72.0 or a refractive diagnosis using any of the 92000 codes if the patient has a routine vision benefit. The insurer also allows medical visits with the 92000 codes when coded appropriately.

Other Articles in this issue of

Ophthalmology and Optometry Coding Alert

View All
Subscribe to newsletter